Any growth factor vs Placebo or no active treatment: Any adverse event (
Growth factors showed no clear difference in any adverse event ( compared with placebo or no therapy (moderate certainty).
What each review found
Current versions only| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Growth factors vs placebo or no therapy Any adverse event ( · people who have been diagnosed with peripheral arterial disease Growth factors showed no clear difference in any adverse event ( compared with placebo or no therapy (moderate certainty). Growth factors for angiogenesis in peripheral arterial disease (2017) · Cochrane Headline outcomes only | OR 1.1 [0.73, 1.64] | 13 studies · 1411 participants | Moderate |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Growth factors for angiogenesis in peripheral arterial disease 2017 · Cochrane Headline outcomes only | Not reported | list not extracted yet | Not assessed |
Studies behind the findings
None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.